|
Alexion Pharmaceuticals Inc (ALXN) |
|
|
|
Alexion Pharmaceuticals Inc 's Revenue per Employee
Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales
With a revenue increase of 13.27% in the first quarter 2021, year on year to cumulative value of $6,262 million, Alexion Pharmaceuticals Inc 's revenue per employee grew on a trailing twelve months basis to $ 1,631,900. The productivity of Alexion Pharmaceuticals Inc 's employees was 8.0632808997051E-11%, above the company average. Within the Healthcare sector employees in only one company have achieved higher revenue/employee than at Alexion Pharmaceuticals Inc . While Alexion Pharmaceuticals Inc 's total ranking has deteriorated compared to the previous quarter from 28 to 85. Alexion Pharmaceuticals Inc has 3,837 employees.
What is Sales per Employee Ratio?
Select the Comparisons :
|
|
Select the Ratio:
|
|
ALXN Revenue per Employee |
(Mar 31 2021) I. Quarter |
(Dec 31 2020) IV. Quarter |
(Sep 30 2020) III. Quarter |
(Jun 30 2020) II. Quarter |
(Mar 31 2020) I. Quarter |
Y / Y Revenue Change |
13.27 % |
14.99 % |
25.78 % |
20.05 % |
26.69 % |
Sales per Employee
(TTM) $ |
1,631,900 |
1,581,939 |
1,527,860 |
1,443,002 |
1,380,115 |
ALXN's Total
Ranking |
# 85 |
# 28 |
# 11 |
# 43 |
# 56 |
Seq. Revenue Change |
2.81 % |
0.2 % |
9.98 % |
-0.01 % |
4.37 % |
Revenue per Employee Statistics |
High |
Average |
Low |
$ 2,031,668 |
$ 1,113,638 |
$ 398,547 |
(Mar 31 2021) |
|
(March 31, 2013) |
Date modified: -0001-11-30T00:00:00+00:00
Companies with similar Revenue per Employee for 12 months ending Mar 31 2021, within Healthcare Sector | Revenue per Employee | Revenue 12 months ending Mar 31 2021 | Number of Employees Mar 31 2021 | Cryoport inc | 2,697,392.42 | $ 83.619 Million | 31 | Exelixis Inc | 1,821,295.05 | $ 1,030.853 Million | 566 | Gilead Sciences Inc | 1,775,277.78 | $ 25,564.000 Million | 14,400 | Vertex Pharmaceuticals Inc | 1,644,841.28 | $ 6,414.881 Million | 3,900 | Alexion Pharmaceuticals Inc | 1,631,899.92 | $ 6,261.600 Million | 3,837 | Bristol myers Squibb Company | 1,329,503.11 | $ 42,810.000 Million | 32,200 | Biogen Inc | 1,311,581.69 | $ 12,604.300 Million | 9,610 | Incyte Corporation | 1,290,789.40 | $ 2,702.913 Million | 2,094 | Amgen Inc | 1,039,834.71 | $ 25,164.000 Million | 24,200 | Moderna Inc | 1,011,854.07 | $ 2,732.006 Million | 2,700 | Abbvie inc | 1,003,900.00 | $ 50,195.000 Million | 50,000 | Regeneron Pharmaceuticals Inc | 887,114.20 | $ 9,197.600 Million | 10,368 | Patterson Companies Inc | 844,580.86 | $ 5,912.066 Million | 7,000 | Enanta Pharmaceuticals Inc | 840,705.36 | $ 94.159 Million | 112 |
|